Janssen Biotech funds Monash rheumatoid arthritis research
Featured in the Australian Financial Review, Labonline,and in Pharmacy Daily, Monash University's multi-year research and commercialisation deal with Johnson & Johnson offshoot, Janssen Biotech, to research the early detection and prevention of rheumatoid arthritis attracted business and trade media interest. The deal means Janssen will have first dibs on new medicines emerging from a research team led by Professor Jamie Rossjohn of Monash's Biomedicine Discovery Institute.